{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-24-012079","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2024-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.072825+00:00","generated_at":"2026-05-31T23:05:53.235957+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Stockholders approve conversion of Series A Preferred Stock for up to $25M financing","bullets":["Proposal approved with 5,356,845 votes for, 79,371 against, 3,043 abstentions; no broker non-votes.","Conversion relates to Securities Purchase Agreement dated May 8, 2024, for total purchase price up to $25,000,000.","Approval required under Nasdaq Rule 5635 for issuance exceeding certain share thresholds.","Special meeting held July 8, 2024; record date May 29, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-24-012079","json":"https://secwatch.observer/filing/0001214659-24-012079.json","markdown":"https://secwatch.observer/filing/0001214659-24-012079.md","text":"https://secwatch.observer/filing/0001214659-24-012079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924012079/0001214659-24-012079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924012079/o782458k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:05:53.235957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}